Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
75 studies found for:    Open Studies | "lung transplantation"
Show Display Options
Rank Status Study
21 Unknown  The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation
Condition: Cystic Fibrosis
Interventions: Procedure: Physiotherapy, exercise, percutaneous gastrostomy feeds;   Drug: Anti-reflux pharmacotherapy
22 Recruiting Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
Conditions: Disorder Related to Lung Transplantation;   Bronchiolitis Obliterans
Intervention:
23 Recruiting PET Assessment of Acute Lung Transplant Rejection
Condition: Lung Disease
Interventions: Drug: [18F]FDG;   Drug: [18F]ISO-1
24 Recruiting Morphofunctional Lung Analysis by PET and CT After Lung Transplantation
Condition: Disorder Related to Lung Transplantation
Intervention:
25 Recruiting Self-hypnosis in Patients Awaiting Lung Transplantation
Condition: Lung Transplantation
Interventions: Behavioral: Self-hypnosis;   Behavioral: Routine practice
26 Recruiting Cryoprobe Transbronchial Lung Biopsy in Lung Transplant Patients
Condition: Lung Transplantation
Interventions: Procedure: Cryoprobe biopsy;   Procedure: Forceps Biopsy
27 Recruiting Preliminary Study of Dornase Alpha to Treat Chest Infections Post Lung Transplant.
Conditions: Lung Transplant Infection;   Lower Respiratory Tract Infection.
Interventions: Drug: Dornase Alpha;   Drug: Isotonic Saline.
28 Recruiting Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency
Interventions: Procedure: Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™;   Device: STEEN Solution™
29 Unknown  Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant
Condition: Primary Graft Dysfunction
Intervention:
30 Recruiting Predictive Value of PIIINP and Urinary NGAL for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)
Conditions: Lung Transplantation;   Cystic Fibrosis;   Renal Failure
Intervention: Biological: Urinary levels of PIIINP and NGAL as a marker of changes in renal function
31 Recruiting Efficacy of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
Condition: Lung Transplantation
Interventions: Drug: standard therapy;   Drug: Everolimus (RAD001) as add-on;   Drug: RAD001
32 Not yet recruiting B Cell Induction in Pediatric Lung Transplantation
Conditions: Heart / Lung Transplant;   Lung Transplant
Interventions: Biological: Rituximab (Rituxan®);   Biological: Placebo for Rituximab (Rituxan®)
33 Recruiting Generic Immunosuppressive Drugs After Lung Transplantation
Condition: Immunosuppressive After Lung Transplantation
Intervention: Other: patient questionnaire (tablet pc based)
34 Unknown  Early Indicators of Chronic Rejection in Lung Transplant
Conditions: Chronic Rejection in Lung Transplant;   Cytokine Production in Bos Post Lung Transplant
Intervention:
35 Not yet recruiting VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation
Condition: End Stage Chronic Obstructive Airways Disease
Intervention:
36 Recruiting Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Conditions: Severe Combined Immunodeficiency (SCID);   Immunodeficiency With Predominant T-cell Defect, Unspecified;   Severe Chronic Neutropenia;   Chronic Granulomatous Disease (CGD);   Hyper IgE Syndromes;   Hyper IgM Deficiencies;   Wiskott-Aldrich Syndrome;   Mendelian Susceptibility to Mycobacterial Disease;   Common Variable Immune Deficiency (CVID)
Intervention: Biological: CD3/CD19 negative allogeneic hematopoietic stem cells
37 Unknown  Pulmonary Rehabilitation and Inspiratory Muscle Training (IMT) for Patients Following Lung Transplantation
Condition: Lung Transplantation
Interventions: Behavioral: Conventional or regular pulmonary rehabilitation program alone;   Device: very low load IMT (sham IMT) alone;   Device: Conventional or regular pulmonary rehabilitation program + targeted inspiratory resistive or threshold IMT;   Device: Targeted inspiratory resistive or threshold IMT alone
38 Recruiting Evaluate Cytomegalovirus (CMV)-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients With CMV-positive Serology (R+) Prior to Transplant and Its Involvement in the Development of CMV Infection
Condition: Cytomegalovirus
Intervention:
39 Recruiting A Comparison of Propofol Based Total Intravenous Anesthesia and Sevoflurane Based Balanced Anesthesia on Renal Protection During Lung Transplantation Under Extracorporeal Membrane Oxygenation - A Prospective, Randomized Trial
Condition: Patients Undergoing Lung Transplantation Under Extracorporeal Membrane Oxygenation
Interventions: Drug: Administration of anesthesia: Propofol;   Drug: Administration of anesthesia: Sevoflurane
40 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung
Conditions: Lung Neoplasms;   Lung Transplantation
Intervention: Device: probe based laser endomicroscopy (pCLE)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years